Evolva Holding SA EVOLVA HOLDING ORD SHS
Evolva Holding SA EVOLVA HOLDING .../ CH1262055788 /
0QQJ
|
14/11/2024 10:39:05
|
Diferencia
-
|
Volumen |
Bid6:00:06 |
Ask6:00:06 |
Capitalización de mecado |
Dividendo A. |
P/E Ratio |
|
0.85CHF
|
-
|
194
Volumen de negocios: 164.90 |
-Volumen de oferta: - |
-Tamaño/ Volumen/ Formato de Ask: - |
4.95 millonesCHF |
- |
- |
Descripción de negocio
Evolva Holding SA (formerly Arpida AG) is a Swiss synthetic biology company, internationally active in sustainable, fermentation-based approaches to ingredients for health, wellness and nutrition. Evolva uses biosynthetic and evolutionary technologies to artificially create and optimise small molecule compounds and their production routes. Evolva’s products include stevia, resveratrol, vanillin, nootkatone and saffron. Evolva is active in consumer healthcare and nutrition as well as in pharma. In both areas they have partnered projects as well as own proprietary programmes.
Consejo de gestión & Consejo de supervisión
| CEO |
| Christian Wichert |
| Consejo de gestión |
| Carsten Däweritz, Anne De Vos, Astrid Schäfer, Gerhard Lobmaier, Philipp Frech |
| Consejo de supervisión |
| Stephan Schindler, Beat In-Albon, Christoph Breucker, Andreas Pfluger, Andreas Weigelt |
Datos de la empresa
| Nombre: |
Evolva Holding SA |
| Dirección: |
Duggingerstraße 23,CH-4153 Reinach |
| Teléfono: |
+41-61-485-2000 |
| Fax: |
+41-61-485-2001 |
| E-mail: |
info@evolva.com
|
| Internet: |
www.evolva.com |
| Industria: |
Biotechnology |
| Sector: |
Biotechnology |
| Subsector: |
Biotechnology |
| Fin del año financiero: |
31/12 |
| Acciones de libre circulación: |
69.53% |
| Fecha de OPI: |
26/04/2023 |
Relación con inversores
| Nombre: |
Doris Rudischhauser |
| IR teléfono: |
+41-79-410-81-88 |
| IR-fax: |
- |
| IR e-mail: |
dorisr@evolva.com
|
